Hyperphosphorylation of RNA Polymerase II in Response to Topoisomerase I Cleavage Complexes and Its Association with Transcription- and BRCA1-dependent Degradation of Topoisomerase I
- 17 June 2008
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 381 (3), 540-549
- https://doi.org/10.1016/j.jmb.2008.06.028
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Transcribing RNA Polymerase II Is Phosphorylated at CTD Residue Serine-7Science, 2007
- Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.2001
- Three RNA Polymerase II Carboxyl-terminal Domain Kinases Display Distinct Substrate PreferencesPublished by Elsevier ,2001
- Topoisomerase I-mediated DNA damageAdvances in Cancer Research, 2001
- BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.2000
- Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication RunoffMolecular and Cellular Biology, 2000
- Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription.Genes & Development, 1997
- The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcriptionCarcinogenesis: Integrative Cancer Research, 1996
- Analysis of topoisomerase I/DNA complexes in patients administered topotecan.1995
- Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.Journal of Biological Chemistry, 1985